Pulmonary Function and response to treatment in pulmonary arterial hypertension (PAH)

Joan Albert Barbera (Barcelona, Spain), Joan Albert Barbera, Nazzareno Galie, Adaani Frost, Hossein Ardeschir Ghofrani, Marius Hoeper, Vallerie Mclaughlin, Andrew Peacock, Gerald Simonneau, Jean-Luc Vachiery, Christiana Blair, Karen Miller, Julia Harris, Jonathan Langley, Lewis Rubin

Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Session: Pulmonary hypertension: the clinic II
Session type: Thematic Poster
Number: 2411

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Joan Albert Barbera (Barcelona, Spain), Joan Albert Barbera, Nazzareno Galie, Adaani Frost, Hossein Ardeschir Ghofrani, Marius Hoeper, Vallerie Mclaughlin, Andrew Peacock, Gerald Simonneau, Jean-Luc Vachiery, Christiana Blair, Karen Miller, Julia Harris, Jonathan Langley, Lewis Rubin. Pulmonary Function and response to treatment in pulmonary arterial hypertension (PAH). Eur Respir J 2016; 48: Suppl. 60, 2411

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sildenafil improves heart rate variability, pulmonary hemodynamics and functional status in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Muscle function and physical activity in patients with idiopathic pulmonary arterial hypertension (IPAH)
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

The evolution of effort tolerance and body composition in patients with idiopathic pulmonary arterial hypertension
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Analysis of pulmonary endothelial microparticles, haemodynamics and functional class in pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Pulmonary hemodynamics and lung function in patients with COPD and DPLD
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Small airways dysfunction in chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Dyspnoea and respiratory muscle mechanics dysfunction in disease
Year: 2015


Pregnancy and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013


Female pulmonary arterial hypertension is associated with decreased microRNA96 expression
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Heart rate recovery in response to disease targeted therapy in pre-capillary pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016


LATE-BREAKING ABSTRACT: Riociguat for the treatment of pulmonary arterial hypertension (PAH): 2-year results from the PATENT-2 long-term extension
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014


Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


The different nature of pulmonary vascular resistant and compliance in reduced and preserved ejection fraction heart failure and associated pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014


CT measured pulmonary artery to aorta ratio as a predictor of pulmonary hypertension in COPD
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


miR-126; link between angiogenesis and exercise intolerance in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced COPD
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Adherence to pulmonary arterial hypertension targeted therapies
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015

Beta-blocker therapy nor hyperoxic breathing lowers ventilatory drive in pulmonary arterial hypertension patients
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014


Non-invasive cardiac output assessment in pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014